Filing Details

Accession Number:
0001179110-20-012333
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-31 13:15:33
Reporting Period:
2020-12-29
Accepted Time:
2020-12-31 13:15:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551152 Abbvie Inc. ABBV Pharmaceutical Preparations (2834) 320375147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761675 Ryan Jeffrey Stewart 1 North Waukegan Road
North Chicago IL 60064
Evp, Commercial Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2020-12-29 25,290 $51.42 76,259 No 4 M Direct
Common Stock, $0.01 Par Value Disposition 2020-12-29 25,290 $105.00 50,969 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to buy) Acquisiton 2020-12-29 25,290 $0.00 25,290 $51.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-02-20 2024-02-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 1,338 Indirect By spouse in trust
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities.
  2. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.